Clinical Trial

Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity

Completed Early Phase 1
View on ClinicalTrials.gov →
Summary
Patients with sleep apnea are at increased risk of developing cardiovascular disease - with women at potentially greater risk than men. Contributing mechanisms are not well understood, but may be related to how women respond to low oxygen and, given over 70% of patients with sleep apnea are obese, the impact of obesity. This project seeks to increase our understanding of mechanisms that may contribute to sex differences in the cardiovascular response to low oxygen with the hope that this knowledge will improve the efficacy of current therapies and support the discovery of novel therapeutics.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-29
critical Primary endpoint(s) modified 2026-07-29
notable Enrollment reduced: 104 -> 73 participants 2026-07-29
Trial Details
NCT Number NCT04436731
Lead Sponsor University of Missouri-Columbia
Conditions Obesity, Healthy, Vasoconstriction, Vasodilation
Enrollment 73 participants
Start Date 2020-12-09
Primary Completion 2026-07-02 (estimated)
Study Completion 2026-07-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-28